Urology Specialist Dr. Ziya Akbulut said that prostate cancer is one of the most common causes of death after lung cancer. Stating that prostate cancer, which is an age-related disease, has become much more important in men, Uzm. Dr. Akbulut said, “Prostate cancer is a type of cancer where we have more opportunities to treat when diagnosed early and early diagnosis is very important. Therefore, we prefer early diagnosis and early treatment in prostate cancer. Prostate cancer is more common in men after the age of 60. There are also patients we have identified up to the age of 40. It is a disease in which sexual functions are affected in men, especially when diagnosed in the early age group. Therefore, the treatment becomes much more specific in young patients.”

‘There is no finding that the patient will notice’

Stating that genetic and environmental factors are involved in prostate cancer, Uzm. Dr. Akbulut said:

“In particular, no genetic transition has been detected. However, genetic transmission is more common in patients diagnosed at a young age. It is important to follow up especially the first-degree male relatives of patients under 50 years of age with prostate cancer, and they also have a risk of developing prostate cancer. But prostate cancer detected in advanced ages is not usually genetically transmitted, that is, it is specific to that person. In addition, one of the most important points of prostate cancer is the absence of any finding that the patient will notice. Generally, patients apply with the complaints of age-related prostate disease. The patient does not show any symptoms. We make the diagnosis of cancer by examining and imaging with a blood test screening test specific to the prostate. The patient may not have any signs directly related to the disease. We recommend men to be tested for prostate cancer after the age of 50. If there is a family history of prostate cancer, we recommend that they have a screening test from the age of 40.”


Emphasizing that the stage of diagnosis is very important in the treatment of prostate cancer, Akbulut said, “If we diagnose prostate cancer at an early stage, we can treat it much more easily. Treatment options include surgery, radiotherapy, and chemotherapy, including follow-up. With the ‘Nanoknife’ treatment, which is a new treatment method, in patients diagnosed with early-stage prostate cancer, only cancerous cells are destroyed without removing the entire prostate gland. When we diagnosed the disease in a certain region of the prostate early, this method was applied to the entire prostate in previous treatment methods. The feature of this treatment is to treat only the diseased part. This is important for every organ, but prostate cancer has its own characteristics. While we are treating prostate cancer, besides treating the cancerous cell in the patient, two important factors affecting the comfort of life are also affected. These are urinary retention or urinary incontinence, maintaining sexual functions because the prostate is an organ very close to these two mechanisms. Treatments applied to the prostate also affect them. The feature of new treatments is to be able to protect these factors.”


Stating that the ‘Nanoknife’ treatment method is a high-current electrical application, Dr. Dr. Akbulut said, “The advantage of this technology has been used in pancreatic tumors for many years. Now we use this treatment method in the prostate as well. A treatment with less side effects and more effective results among ablation treatments. It can be reapplied, after this treatment, it does not prevent other treatment options. So this is a technological approach. If the tumor detected in the prostate is a low and middle stage tumor, smaller than 2 centimeters, we only treat that tumor with the ‘Nanoknife’ method. It treats only the cancerous cell with special electrodes placed around the tumor. A method that protects the prostate tissue and treats only the diseased area. This is a technological treatment in which the patient can return to his normal life in a few days as if a biopsy sample is taken without harming his urinary functions and sexual functions. Again, as I said, early diagnosis, the stage of the disease and the age of the patient are very important here. These are the treatments of the future, and they will be the methods that we will talk about and apply the most in the next 5 years.

Leave a Reply

Your email address will not be published. Required fields are marked *